Moclobemide in Modern Therapeutics: Beyond Depression Treatment
Moclobemide, a pharmaceutical intermediate with the CAS number 71320-77-9, is widely recognized for its role in treating depression. However, its therapeutic potential extends beyond this primary indication, making it a compound of significant interest in contemporary medicine. NINGBO INNO PHARMCHEM CO.,LTD. supplies this high-quality intermediate, enabling advancements in various treatment modalities.
While Moclobemide is a cornerstone in the synthesis of antidepressants, its efficacy in managing social anxiety disorder is also well-documented. As a reversible inhibitor of monoamine oxidase A (RIMA), it offers a nuanced approach to neurotransmitter modulation, which is beneficial for a range of psychiatric conditions. The compound's favorable safety profile, particularly its lack of significant anticholinergic and cardiovascular side effects, makes it an attractive option for patient populations that may not tolerate older medications well. This includes the elderly, where cognitive function and cardiovascular health are often primary concerns. NINGBO INNO PHARMCHEM CO.,LTD. provides this essential pharmaceutical intermediate, supporting its broader therapeutic applications.
The advantages of Moclobemide as a reversible MAOI intermediate also contribute to its utility in clinical settings. Unlike irreversible MAOIs, it does not necessitate strict dietary restrictions regarding tyramine-rich foods, thus simplifying patient management and reducing the risk of adverse drug-food interactions. This enhanced tolerability and safety profile are key factors driving demand for this high-quality pharmaceutical intermediate. Manufacturers seeking to produce advanced therapeutics can rely on the consistent quality of our CAS 71320-77-9 chemical to meet rigorous pharmaceutical standards.
The competitive antidepressant raw material price makes Moclobemide an accessible option for pharmaceutical research and development. NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to supporting innovation in mental health by providing this vital chemical. The ongoing exploration of Moclobemide's therapeutic benefits underscores its importance as a versatile pharmaceutical intermediate in the ongoing quest for improved patient outcomes.
Perspectives & Insights
Alpha Spark Labs
“supplies this high-quality intermediate, enabling advancements in various treatment modalities.”
Future Pioneer 88
“While Moclobemide is a cornerstone in the synthesis of antidepressants, its efficacy in managing social anxiety disorder is also well-documented.”
Core Explorer Pro
“As a reversible inhibitor of monoamine oxidase A (RIMA), it offers a nuanced approach to neurotransmitter modulation, which is beneficial for a range of psychiatric conditions.”